Hims & Hers Health Share Price (NYSE: HIMS)

$43.21

▲

-0.91

(-2.06%)

Live

Last updated on August 30, 2025 at 12:41 am IST

$₹

Check the interactive Hims & Hers Health Stock chart to analyse performance

Hims & Hers Health stock performance

as on August 30, 2025 at 12:41 am IST

Today's Low:$42.90
Today's High:$44.33
$43.21
0.72%
Downside
Day's Volatility :3.23%
Upside
2.53%
52 Weeks Low:$13.47
52 Weeks High:$72.98
$43.21
68.83%
Downside
52 Weeks Volatility :81.54%
Upside
40.79%

Hims & Hers Health Stock Returns

Period	Hims & Hers Health Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.92%	3.1%	0.0%
6 Months	-2.06%	-8.4%	0.0%
1 Year	199.8%	-12.6%	0.0%
3 Years	606.56%	7.9%	-6.1%

Hims & Hers Health Inc Key Stats

Check Hims & Hers Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$44.12
Open	$44.47
Today's High	$44.33
Today's Low	$42.56
Market Capitalization	$9.9B
Today's Volume	$17.7M
52 Week High	$72.98
52 Week Low	$13.47
Revenue TTM	$2.0B
EBITDA	$160.2M
Earnings Per Share (EPS)	$0.79
PE Ratio	55.71
Profit Margin	9.61%
Quarterly Earnings Growth YOY	1.98%
Return On Equity TTM	41.88%

Stock Returns calculator for Hims & Hers Health Stock including INR - Dollar returns

The Hims & Hers Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Hims & Hers Health investment value today

Current value as on today

₹2,98,524

Returns

₹1,98,524

(+198.52%)

Returns from Hims & Hers Health Stock

₹1,93,347 (+193.35%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Hims & Hers Health Stock

18.96%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Investment in Hims & Hers Health Shares from India has grown by 18.96% over the past 30 days, indicating increased transactional activity.

-3%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Hims & Hers Health Stock from India on INDmoney has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Hims & Hers Health Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
10.74%
Vanguard Group Inc
8.27%
Capital World Investors
8.22%
Goldman Sachs Group Inc
3.62%
Farallon Capital Management, L.L.C.
3.52%
State Street Corp
3.30%

Analyst Recommendation on Hims & Hers Health Stock

Rating

Trend

Buy

68%Buy

31%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Hims & Hers Health(by analysts ranked 0 to 5 stars)

Hims & Hers Health Share Price Target

What analysts predicted

Upside of 14.45%

Target:

$49.45

Current:

$43.21

Hims & Hers Health share price target is $49.45, a slight Upside of 14.45% compared to current price of $43.21 as per analysts' prediction.

Hims & Hers Health Stock Insights

Price Movement
In the last 1 month, HIMS stock has moved down by -26.7%
Decreasing Revenue
Revenue is down for the last 2 quarters, 586.01M → 544.83M (in $), with an average decrease of 7.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 49.48M → 42.50M (in $), with an average decrease of 14.1% per quarter

Hims & Hers Health Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$82.6M	↑ 209.45%
Net Income	$-72.1M	↓ 4.22%
Net Profit Margin	-87.29%	↑ 194.74%

	FY20	Y/Y Change
Revenue	$148.8M	↑ 80.18%
Net Income	$-18.1M	↓ 74.86%
Net Profit Margin	-12.18%	↑ 75.11%

	FY21	Y/Y Change
Revenue	$271.9M	↑ 82.77%
Net Income	$-107.7M	↑ 494.34%
Net Profit Margin	-39.6%	↓ 27.42%

	FY22	Y/Y Change
Revenue	$526.9M	↑ 93.81%
Net Income	$-65.7M	↓ 38.99%
Net Profit Margin	-12.46%	↑ 27.14%

	FY23	Y/Y Change
Revenue	$872.0M	↑ 65.49%
Net Income	$-23.5M	↓ 64.15%
Net Profit Margin	-2.7%	↑ 9.76%

	FY24	Y/Y Change
Revenue	$1.5B	↑ 69.33%
Net Income	$126.0M	↓ 635.28%
Net Profit Margin	8.54%	↑ 11.24%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$278.2M	↑ 12.79%
Net Income	$11.1M	↑ 793.82%
Net Profit Margin	4.0%	↑ 3.5%

	Q2 FY24	Q/Q Change
Revenue	$315.6M	↑ 13.47%
Net Income	$13.3M	↑ 19.49%
Net Profit Margin	4.21%	↑ 0.21%

	Q3 FY24	Q/Q Change
Revenue	$401.6M	↑ 27.22%
Net Income	$75.6M	↑ 468.46%
Net Profit Margin	18.82%	↑ 14.61%

	Q4 FY24	Q/Q Change
Revenue	$481.1M	↑ 19.82%
Net Income	$26.0M	↓ 65.57%
Net Profit Margin	5.41%	↓ 13.41%

	Q1 FY25	Q/Q Change
Revenue	$586.0M	↑ 21.8%
Net Income	$49.5M	↑ 90.14%
Net Profit Margin	8.44%	↑ 3.03%

	Q2 FY25	Q/Q Change
Revenue	$544.8M	↓ 7.03%
Net Income	$42.5M	↓ 14.11%
Net Profit Margin	7.8%	↓ 0.64%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$44.6M	↑ 471.64%

	FY20	Y/Y Change
Profit	$109.5M	↑ 145.38%

	FY21	Y/Y Change
Profit	$204.5M	↑ 86.84%

	FY22	Y/Y Change
Profit	$408.7M	↑ 99.87%

	FY23	Y/Y Change
Profit	$714.9M	↑ 74.92%

	FY24	Y/Y Change
Profit	$1.2B	↑ 64.09%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$229.1M	↑ 12.27%

	Q2 FY24	Q/Q Change
Profit	$256.6M	↑ 12.01%

	Q3 FY24	Q/Q Change
Profit	$317.9M	↑ 23.88%

	Q4 FY24	Q/Q Change
Profit	$369.5M	↑ 16.25%

	Q1 FY25	Q/Q Change
Profit	$430.7M	↑ 16.55%

	Q2 FY25	Q/Q Change
Profit	$416.2M	↓ 3.37%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-74.9M	↑ 30.61%
Investing Cash Flow	$-39.3M	↑ 491137.5%
Financing Cash Flow	$95.3M	↑ 21.97%

	FY20	Y/Y Change
Operating Cash Flow	$-2.5M	↓ 96.69%
Investing Cash Flow	$-39.7M	↑ 1.02%
Financing Cash Flow	$47.7M	↓ 49.91%

	FY21	Y/Y Change
Operating Cash Flow	$-34.4M	↑ 1288.14%
Investing Cash Flow	$-156.3M	↑ 293.61%
Financing Cash Flow	$235.0M	↑ 392.32%

	FY22	Y/Y Change
Operating Cash Flow	$-26.5M	↓ 22.9%
Investing Cash Flow	$34.7M	↓ 122.2%
Financing Cash Flow	$-33.1M	↓ 114.09%

	FY23	Y/Y Change
Operating Cash Flow	$73.5M	↓ 376.97%
Investing Cash Flow	$-12.1M	↓ 134.89%
Financing Cash Flow	$-11.5M	↓ 65.36%

	FY24	Y/Y Change
Operating Cash Flow	$251.1M	↑ 241.69%
Investing Cash Flow	$-19.0M	↑ 57.34%
Financing Cash Flow	$-107.8M	↑ 839.83%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$25.8M	↑ 17.54%
Investing Cash Flow	$13.0M	↓ 36.98%
Financing Cash Flow	$-30.3M	↑ 664.77%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$53.6M	↑ 107.42%
Investing Cash Flow	$-4.5M	↓ 134.27%
Financing Cash Flow	$-25.1M	↓ 17.3%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$85.3M	↑ 59.1%
Investing Cash Flow	$-10.4M	↑ 132.98%
Financing Cash Flow	$-38.8M	↑ 54.88%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$86.4M	↑ 1.31%
Investing Cash Flow	$-17.2M	↑ 65.22%
Financing Cash Flow	$-13.7M	↓ 64.83%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$109.1M	↑ 26.28%
Investing Cash Flow	$-32.8M	↑ 90.61%
Financing Cash Flow	$-23.0M	↑ 68.61%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-19.1M	↓ 117.52%
Investing Cash Flow	$-21.1M	↓ 35.7%
Financing Cash Flow	$889.2M	↓ 3962.93%

Hims & Hers Health Technicals Summary

Sell

Neutral

Buy

Hims & Hers Health is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hims & Hers Health Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Hims & Hers Health Inc	-32.61%	-2.06%	199.8%	606.56%	186.2%
Colgate-palmolive Co.	-2.82%	-8.54%	-21.2%	5.54%	5.2%
Procter & Gamble Company, The	1.79%	-10.48%	-8.47%	11.01%	12.5%
Estée Lauder Companies Inc.	-1.96%	27.69%	1.38%	-64.29%	-58.59%
Kenvue Inc.	-5.26%	-12.97%	-5.56%	-23.64%	-23.64%
Kimberly-clark Corp.	2.72%	-9.37%	-10.14%	-0.1%	-18.42%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Hims & Hers Health Inc	55.71	55.71	5.23	1.07	0.42	0.07	NA	2.49
Colgate-palmolive Co.	23.43	23.43	1.81	3.68	0.4	0.16	0.02	0.87
Procter & Gamble Company, The	24.15	24.15	3.78	6.78	0.31	0.11	0.03	21.88
Estée Lauder Companies Inc.	124.05	NA	1.97	1.49	-0.25	0.03	0.02	10.74
Kenvue Inc.	27.67	27.67	1.14	1.03	0.14	0.07	0.04	5.59
Kimberly-clark Corp.	17.81	17.81	5.67	7.52	1.84	0.11	0.04	3.83

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Hims & Hers Health Inc	Buy	$9.9B	186.2%	55.71	9.61%
Colgate-palmolive Co.	Buy	$67.4B	5.2%	23.43	14.54%
Procter & Gamble Company, The	Buy	$367.7B	12.5%	24.15	18.95%
Estée Lauder Companies Inc.	Hold	$33.3B	-58.59%	124.05	-7.91%
Kenvue Inc.	Buy	$39.8B	-23.64%	27.67	9.37%
Kimberly-clark Corp.	Hold	$43.2B	-18.42%	17.81	12.32%

About Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Organization	Hims & Hers Health
Employees	1637
CEO	Mr. Andrew Dudum
Industry	Healthcare

Key Management of Hims & Hers Health Inc

Name	Title
Mr. Andrew Dudum	Co-Founder, Chairman & CEO
Mr. Oluyemi Okupe	Chief Financial Officer
Ms. Soleil Teubner Boughton J.D.	Chief Legal Officer & Corporate Secretary
Dr. Patrick Carroll M.D.	Chief Medical Officer & Director
Mr. Mike Chi	Chief Commercial Officer
Mr. Nader Kabbani	Chief Operations Officer
Ms. Irene A. Becklund	Senior VP, Controller & Principal Accounting Officer
Mr. Mohamed ElShenawy	Chief Technology Officer
Dr. Peter Stahl M.D.	Senior Vice President of Men's Reproductive & Sexual Health
Dr. Daniel Lieberman M.D.	Senior Vice President of Mental Health

Important FAQs about investing in HIMS Stock from India :

What is Hims & Hers Health share price today?

Hims & Hers Health share price today is $43.21 as on August 30, 2025 at 12:41 am IST. Hims & Hers Health share today touched a day high of $44.33 and a low of $42.90.

What is the 52 week high and 52 week low for Hims & Hers Health share?

Hims & Hers Health share touched a 52 week high of $72.98 and a 52 week low of $13.47. Hims & Hers Health stock price today i.e. August 30, 2025 at 12:41 am IST is trending at $43.21, lower by 40.79% versus the 52 week high.

How to invest in Hims & Hers Health Stock (HIMS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hims & Hers Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hims & Hers Health Shares that will get you 0.0347 shares as per Hims & Hers Health share price of $43.21 per share as on August 30, 2025 at 12:41 am IST.

What is the minimum amount required to buy Hims & Hers Health Stock (HIMS) from India?

Indian investors can start investing in Hims & Hers Health (HIMS) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Hims & Hers Health stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Hims & Hers Health share’s latest price of $43.21 as on August 30, 2025 at 12:41 am IST, you will get 0.2314 shares of Hims & Hers Health. Learn more about fractional shares .

What are the returns that Hims & Hers Health has given to Indian investors in the last 5 years?

Hims & Hers Health stock has given 186.2% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?